Imagen de Portada

Common Severity‐Based Definitions of Bronchopulmonary Dysplasia Are not Associated With Outpatient Morbidities

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Robin L. McKinney, Antonia P. Popova, Milenka Cuevas Guaman, Matthew J. Kielt, Paul E. Moore, Sharon A. McGrath‐Morrow, Joseph M. Collaco
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pediatric Pulmonology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Bronchopulmonary Dysplasia Definitions As Predictors of Early Childhood Pulmonary Function
por: Brianna C. Aoyama, et al.
Publicado: (2025)

Caregiver Social Needs and Outpatient Respiratory Outcomes in a Cohort of Children With Bronchopulmonary Dysplasia
por: Danielle Carlin, et al.
Publicado: (2025)

Outpatient Medication Prescribing Patterns in Bronchopulmonary Dysplasia: A Survey of Clinical Practices and Challenges
por: Michael C. Tracy, et al.
Publicado: (2026)

Lower Respiratory Tract Bacterial Profiles Are Associated With Respiratory Severity and Bronchopulmonary Dysplasia in Neonates
por: Jelte Kelchtermans, et al.
Publicado: (2025)

Outpatient Respiratory Outcomes in Extremely Preterm Children During the First 3 Years of Life
por: Cynara Leon, et al.
Publicado: (2025)

Increased Mean Airway Pressure Is Associated With Successful Transition to a Portable Home Ventilator in Patients With Grade 3 Bronchopulmonary Dysplasia
por: Robin L McKinney, et al.
Publicado: (2025)

Social determinants of health and somatic growth in preterm infants and children with chronic lung disease
por: Brianna C. Aoyama, et al.
Publicado: (2024)

Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia
por: Cynara Leon, et al.
Publicado: (2024)

Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia
por: Haley Urbach, et al.
Publicado: (2025)

Outpatient Medications Deimplemented by the AAP Bronchiolitis Guidelines: An Umbrella Review of Meta‐Analyses
por: Larry Mellick, et al.
Publicado: (2024)

Bronchopulmonary Dysplasia in the First Year: Insights Into Severity, Medication Use, and Healthcare Utilization
por: Eliaz Brumer, et al.
Publicado: (2025)

Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia
por: Tal‐El Ernest, et al.
Publicado: (2025)

The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
por: Stephanie M. Tsoi, et al.
Publicado: (2026)

Urine Metabolomics to Predict Bronchopulmonary Dysplasia: A Single‐Center Prospective Study
por: Lauren Strauch, et al.
Publicado: (2026)

Effectiveness of Intratracheal Surfactant Mixed With Budesonide for Prevention of Bronchopulmonary Dysplasia
por: Adnan S. Ahmad, et al.
Publicado: (2025)

Noninvasive Neurally Adjusted Ventilatory Assist for the Management of Severe Tracheobronchomalacia in a Preterm Infant With Bronchopulmonary Dysplasia: A Case Report
por: Dina W. Abdulghani, et al.
Publicado: (2026)

Associations of Community Material Neighborhood Deprivation With the Diagnosis of Asthma Among Infants With Bronchopulmonary Dysplasia (BPD)
por: Jonathan J. Szeto, et al.
Publicado: (2026)

Predictors of Bronchodilator Response on Oscillometry and Spirometry in School‐Age Children With Bronchopulmonary Dysplasia
por: Julia. X. Lee, et al.
Publicado: (2025)

Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study
por: Yali Zeng, et al.
Publicado: (2024)

Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
por: Melissa House, et al.
Publicado: (2025)

Identification and Validation of TFF3 as a Diagnostic Biomarker and Therapeutic Agent for Bronchopulmonary Dysplasia
por: Zhenzhuang Zou, et al.
Publicado: (2025)

Exercise Capacity and Ventilatory Response in Children Who Were Born Preterm, With and Without Bronchopulmonary Dysplasia
por: Eleana Kouroukli, et al.
Publicado: (2026)

Current Practices for Bronchopulmonary Dysplasia‐Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain
por: Macarena García‐Gozalo, et al.
Publicado: (2025)

Using Positive End‐Expiratory Pressure to Predict and Quantify Tracheobronchomalacia in Grade 3 Bronchopulmonary Dysplasia
por: Stephanie A. Adaikalam, et al.
Publicado: (2025)

Dynamic Risk‐Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants
por: Ting Zhao, et al.
Publicado: (2025)

Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants
por: Genichiro Sotodate, et al.
Publicado: (2025)

Comment on “Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants”
por: Yi‐Li Hung, et al.
Publicado: (2026)

Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta‐Analysis
por: Kaixu Wang, et al.
Publicado: (2025)

Lung Ultrasound and Lung Clearance Index After Preterm Birth: A Structure‐Function Framework for Bronchopulmonary Dysplasia and Post‐Prematurity Respiratory Disease
por: Jan Neneman, et al.
Publicado: (2026)

Nasal High‐Flow Therapy Versus Low‐Flow Oxygen Therapy Post‐Discharge in Infants With Bronchopulmonary Dysplasia: A Retrospective Observational Study
por: Alessia Mariani, et al.
Publicado: (2024)

Bronchopulmonary dysplasia severity and bone status in preterm infants
por: Ariel Tarrell, et al.
Publicado: (2024)

Recent Evidence on Indoor Air Pollutants and Pediatric Asthma Morbidity
por: Julia. X. Lee, et al.
Publicado: (2026)

Adding fuel to the fire: The growing case for global access to cystic fibrosis transmembrane conductance regulator modulator therapy
por: Brenda M. Morrow, et al.
Publicado: (2024)

Personalized lung care: Bronchopulmonary dysplasia risk prediction tool tailored for neonates born in resource‐limited settings
por: Flávia Maria de Medeiros Cavalcante Meneghetti, et al.
Publicado: (2024)

Use or Overuse of Systemic Glucocorticoids in Children With Acute Conditions in the Outpatient Setting
por: Sergio Verd, et al.
Publicado: (2026)

Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
por: Cameron J. McKinzie, et al.
Publicado: (2024)

Pulmonary Morbidity in Congenital Diaphragmatic Hernia Survivors Treated at a Non‐ECMO Center From 1998 to 2015: A Cross‐Sectional Study
por: Ulla Lei Larsen, et al.
Publicado: (2025)

PulmZoom: Yield for Targeted Gene Panels in Genetically‐Mediated Respiratory Disorders
por: Sara C. Sadreameli, et al.
Publicado: (2025)

Childhood Interstitial Lung Disease (chILD) Associated With Toxic Chemical Inhalation Exposures: A State‐of‐the‐Art Review
por: William Hadley, et al.
Publicado: (2025)

Navigating Recommendation Versus Reality: Considering Social Determinants of Health in Discharge and Outpatient Management of Children Requiring Home Mechanical Ventilation
por: Annie B. Friedrich, et al.
Publicado: (2025)